Advertisement
Research ArticleArticle

Pharmacokinetics and Disposition of the Thiouracil Derivative PF-06282999, an Orally Bioavailable, Irreversible Inactivator of Myeloperoxidase Enzyme, Across Animals and Humans

Jennifer Q. Dong, Manthena V. Varma, Angela Wolford, Tim Ryder, Li Di, Bo Feng, Steven G. Terra, Kazuko Sagawa and Amit S. Kalgutkar
Drug Metabolism and Disposition February 2016, 44 (2) 209-219; DOI: https://doi.org/10.1124/dmd.115.067868
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleArticle

Disposition of PF-06282999 in Animals and Humans

Jennifer Q. Dong, Manthena V. Varma, Angela Wolford, Tim Ryder, Li Di, Bo Feng, Steven G. Terra, Kazuko Sagawa and Amit S. Kalgutkar
Drug Metabolism and Disposition February 1, 2016, 44 (2) 209-219; DOI: https://doi.org/10.1124/dmd.115.067868
Reddit logo Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement